View drug registration information details.
Items | Registration information |
ID | 299 |
No | 299 |
Brand Name | DIABETMIN 850 |
Ingredients | METFORMIN HYDROCHLORIDE 850 MG |
Dosage Form | FILM COATED TABLET |
Primary Packaging | BLISTERPACK |
Storage | STORE BELOW 30C, PROTECT FROM LIGHT AND MOISTURE |
Shelf Life | 3 YEARS |
Pack Size | BOX OF 10 X 10'S |
Dispensing Category | Prescription only |
ATC Classification | |
Pharmaceutical Class | ANTIDIABETE |
Indications | TREATMENT OF NON-INSULIN-DEPENDENT DIABETES MELLITUS (TYPE 2) IN ADULTS, NOT RESPONDING TO EXCERCISE AND DIETARY MODIFICATION, DIABETMIN MAY BE USED AS MONOTHERAPY OR IN COMBINATION WITH OTHER ORAL ANTIDIABETIC AGENT, OR WITH INSULIN. |
Contraindications | HYPERSENSITIVITY, ANY CONDITION NEEDING CLOSE BLOOD GLUCOSE CONTROL, CONDITION ASSOCIATED WITH HYPOXEMIA, SEVERE, ACUTE, CHRONIC HEPATIC DISEASE, DIAGNOSTIC OR MEDICAL EXAMINATION USING INTRAVASCULAR IODINATED CONTRAST MEDIA |
Side Effects | ANOREXIA, DIARRHEA, DYSPEPSIA, FLATULENCE, NAUSEA, VOMITING, HEADACHE, MATALLIC TASTE, WEIGHT LOSS, ANEMIA, MEGALOBLASTIC, HYPOGLYCEMIA, LACTIC ACIDOSIS |
Unit Price | |
EDL |
Yes |
Description | ROUND, WHITE FILM COATED TABLET WITH DEEP CONVEX FACES AND "HOVID" EMBOSSED ON ONE FACE |
Note | |
License Owner | BMS PHARMA SOLE CO.,LTD |
Manufacturer | HOVID BHD |
Country | MALAYSIA |
Import Registration No | MAL05051079AZ |
Import Registration Date | 28/05/2015 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2023-03-31 |
FDD Registration No | 04 I 4911/20 |
FDD Registration Date | 2023-06-07 |
Expiry Date | 2026-06-06 |
Back to drug list
|